Trial Profile
Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Apremilast (Primary) ; Doxycycline
- Indications Pemphigoid
- Focus Therapeutic Use
- Acronyms SAMP trial
- 16 May 2019 Status changed to recruiting.
- 14 Aug 2018 New trial record